Veterinary Medicines

Fypryst Combo 134 mg/ 120.6 mg spot-on solution for medium dogs

Authorised
  • (S)-Methoprene
  • Fipronil
Download as PDF

Product identification

Medicine name:
Fypryst Combo 134 mg/ 120.6 mg spot-on solution for medium dogs
Fypryst Combo 134 mg/pipetę + 120,6 mg/pipetę Roztwór do nakrapiania
Active substance:
  • (S)-Methoprene
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • (S)-Methoprene
    120.60
    milligram(s)
    /
    1.34
    millilitre(s)
  • Fipronil
    134.00
    milligram(s)
    /
    1.34
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • White polypropylene single-dose pipette packaged in aluminium foil sachets. Cardboard box containing 1pipette
  • White polypropylene single-dose pipette packaged in aluminium foil sachets. Cardboard box containing 10 pipettes
  • White polypropylene single-dose pipette packaged in aluminium foil sachets. Cardboard box containing 6 pipettes
  • White polypropylene single-dose pipette packaged in aluminium foil sachets. Cardboard box containing 3 pipettes

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2421
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0133/002/DC
Concerned member states:
  • Bulgaria
  • Croatia
  • Estonia
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovenia
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."